T 2259/22 of 28.11.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T225922.20241128
- Date of decision
- 28 November 2024
- Case number
- T 2259/22
- Online on
- 27 February 2025
- Petition for review of
- -
- Application number
- 17709795.3
- IPC class
- A61F 2/856A61F 2/24
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- TREATMENT OF TRICUSPID INSUFFICIENCY
- Applicant name
- Innoventric Ltd.
- Opponent name
- MEDIRA GmbH
- Board
- 3.2.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 111(1)European Patent Convention Art 113(1)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention R 106Rules of procedure of the Boards of Appeal 2020 Art 011Rules of procedure of the Boards of Appeal 2020 Art 012(3)Rules of procedure of the Boards of Appeal 2020 Art 012(5)
- Keywords
- Novelty - (yes)
Inventive step - (yes)
Obligation to raise objections - objection dismissed
Statement of grounds of appeal - insufficient substantiation of objections (no)
Statement of grounds of appeal - objections admitted (yes)
Remittal - special reasons for remittal (no) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision is set aside.
2. The patent is maintained on the basis of the
main request.